Home » Authors » Amanda Pedersen

Articles by Amanda Pedersen

Impulse completes enrollment in Optimizer III FIX-HF-5 trial

June 8, 2007

By Amanda Pedersen

DexCom’s Seven is next step in continuous glucose monitoring

June 7, 2007

By Amanda Pedersen

New ventures: Endovasc creates BioFlow unit to develop biodegradable stents

June 7, 2007

By Amanda Pedersen

Agreements: Cardio3 BioSciences partners with Mayo Clinic for stem cell research

June 7, 2007

By Amanda Pedersen

ev3 to study EverFlex stent for treatment of PAD under an IDE

June 6, 2007

By Amanda Pedersen

AMO to focus on rub solutions In wake of Moisture Plus recall

June 6, 2007

By Amanda Pedersen

DexCom s Seven is next step in continuous glucose monitoring

June 4, 2007

By Amanda Pedersen

Flo 24 trial extends treatment for Ischemic stroke up to 24 hours

June 4, 2007

By Amanda Pedersen

Acorn gets FDA okay for new trial of CorCap device

June 1, 2007

By Amanda Pedersen

MIS need for OSA therapy fuels strong response to Aspire trial

May 29, 2007

By Amanda Pedersen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026